⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 28, 2024ESC Heart FailureOpen Access

Intravenous iron and SGLT2 inhibitors in iron‐deficient patients with heart failure and reduced ejection fraction

Kieran F. Docherty John J.V. McMurray Paul R. Kalra John G.F. Cleland Ninian N. Lang Mark C. Petrie Michele Robertson Ian Ford

View Full Paper

Ask AI

Bookmark

Share

Abstract

To explore the potential interaction between use of SGLT2 inhibitors and the increase in haemoglobin in patients randomized to intravenous iron or the control group in the IRONMAN (Effectiveness of Intravenous Iron Treatment versus Standard Care in Patients with Heart Failure and Iron Deficiency) trial.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Docherty et al. (2024) studied this question.

synapsesocial.com/papers/68e71ec4b6db643587698229 https://doi.org/10.1002/ehf2.14742

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Erythropoietic Response After Intravenous Iron in Patients with Heart Failure and Reduced Ejection Fraction with and Without Background Treatment with Sodium–Glucose Cotransporter 2 Inhibitorscohort · 2023 · 27 citations
2Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial2024 · 44 citations
3IV Sodium Ferric Gluconate Complex in Patients With Iron Deficiency Hospitalized due to Acute Heart Failure—Investigator Initiated, Randomized Controlled TrialRCT · 2022 · 12 citations
4Safety and Effectiveness of an Accelerated Intravenous Iron Administration Protocol in Hospitalized Patients With Heart Failurecohort · 2021 · 9 citations
5Intravenous iron therapy for iron deficiency in patients with heart failure: An updated systematic review and meta-analysismeta-analysis · 2023 · 3 citations

Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials2023
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial2025
Iron Therapy for the Treatment of Iron Deficiency in Chronic Heart Failure: Intravenous or Oral?2015
Sex-Specific Prognostic Significance of Interventricular Septal Thickness in Heart FailureESC Heart Failure · 2026
Sex-Specific Mechanisms and Therapeutics in Heart Failure: Translating Biology into Personalized CareESC Heart Failure · 2026

More from ESC Heart Failure

More from University of Glasgow

More from University of Portsmouth

More from Portsmouth Hospitals NHS Trust